Literature DB >> 2612746

Increase in permeability and phospholipase A2 activity of colonic mucosa in Crohn's colitis.

G Olaison1, P Leandersson, R Sjödahl, C Tagesson.   

Abstract

Patients with Crohn's colitis were investigated regarding the relationship between intestinal inflammation, mucosal activity of phospholipase A2 and intestinal permeability to different-sized polyethylene glycols (PEG). Mucosal specimens for phospholipase A2 were obtained at colonoscopy and PEG (590-942 daltons) were deposited in the descending colon. Colonic absorption was measured as urinary output of deposited PEG. Colonic absorption of PEG was higher in these patients, even when the colitis was in remission at colonoscopy, than in ileal Crohn's disease or control patients. Mucosal phospholipase A2 activity was increased in active colitis, but in the patients with endoscopic remission it was at the same level as in the controls or in the patients with ileal Crohn's disease. The observations suggest that increased intestinal permeability may be a primary factor in activation of mucosal phospholipase A2 activity and in intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612746     DOI: 10.1159/000199881

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

1.  Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.

Authors:  T Minami; H Tojo; Y Shinomura; S Tarui; M Okamoto
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.

Authors:  J W Peterson; W D Dickey; S S Saini; W Gourley; G R Klimpel; A K Chopra
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

3.  Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.

Authors:  Shuhei Agawa; Seiji Futagami; Hiroshi Yamawaki; Rina Tsushima; Kazutoshi Higuchi; Mayu Habiro; Rie Kawawa; Yasuhiro Kodaka; Nobue Ueki; Yoshiyuki Watanabe; Katya Gudis; Rhuji Ohashi; Katsuhiko Iwakiri
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

4.  Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis.

Authors:  S Almer; L Franzén; G Olaison; K Smedh; M Ström
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

5.  Phospholipase A2 and mediation of the activation of short-circuit current in the rat colonic mucosa.

Authors:  M Diener; W Rummel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

6.  Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.

Authors:  I Sobhani; S Hochlaf; Y Denizot; C Vissuzaine; E Rene; J Benveniste; M M Lewin; M Mignon
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

7.  PAF-acether and acetylhydrolase in stool of patients with Crohn's disease.

Authors:  Y Denizot; S Chaussade; N Nathan; J F Colombel; M J Bossant; N Cherouki; J Benveniste; D Couturier
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

8.  Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.

Authors:  T Minami; H Tojo; Y Shinomura; Y Matsuzawa; M Okamoto
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

Review 9.  Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center.

Authors:  Hiroto Miwa; Tadayuki Oshima; Toshihiko Tomita; Hirokazu Fukui; Takashi Kondo; Takahisa Yamasaki; Jiro Watari
Journal:  J Gastroenterol       Date:  2019-02-14       Impact factor: 7.527

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.